Cephalon, a US-based drug maker, has filed a lawsuit against Lupin Ltd and its US subsidiary Lupin Pharmaceuticals for challenging the patents on its sleep disorder drug Nuvigil.
Imagine this scenario. Pyarelal Shankar a grocery store owner in Haryana is not computer literate. Yet, he manages to regularly update his inventory online.
Bangalore-based information technology services firm MindTree has set up an ambitious target of becoming a $1-billion (around Rs 4,600-crore) company over the next five years.
Andrew Witty, chief executive of GlaxoSmithKline (GSK), the world's second-largest drug company, was in India this week as part of the dedication of an albandazole manufacturing facility at Nashik to the World Health Organization (WHO)'s global programme to eliminate Lymphatic Filariasis.
The recent case of embezzlement by a Wipro insider, believe industry experts and analysts, would have little impact on the company's business or image. However, they simultaneously caution that the issue yet again highlights the need for better measures on corporate governance and fraud.
The plethora of new pricing schemes from telecom companies, like 'one paisa per second' billing, has squeezed the margins of their business process outsourcing partners.
The proportion of women to men falls radically after the mid-management level.
Professional services firm Ernst & Young bagged the contract from UIDAI to become consulting partner for the project.
The increases are expected to be in the 8 to 12 per cent range, which do not compare too badly with the 13 to 15 per cent increments of pre-slowdown years such as 2007-08.
The project involves building a network around a dozen secured centres, each priced at pound 250 mn.
If most of the top 10 Indian drug companies were less than Rs 500-crore (Rs 5-billion) turnover ones a decade earlier and were focused only on domestic business, now they are companies with annual businesses ranging from Rs 2,000-Rs 6,000 crore (Rs 20-60 billion) and with operations spanning 60-100 countries and employing 3,000-5,000 people.
India's second largest IT company, Infosys Technologies, for instance, has narrowed on the new areas to drive its growth.
National Association of Software and Service Companies had a humble beginning.
An analysis of the growth rate of 15 leading drug companies for the third quarter of 2008-09 show excellent performances in domestic turf have been often marred by the poor show of their acquired assets.
The sector may not touch the 30-40 per cent growth rates it witnessed before the slowdown, but an register above 20 per cent growth as it nears calendar year 2011, says Partha Iyengar, regional research head and Vice President, Gartner India.
The deal size could be in excess of Rs 2,000 crore, though this could not be verified. Sivasankaran had invested close to Rs 1,800 crore in 2007 to take a 41 per cent stake in Aamby Valley. The Sahara Group is the majority investor, with a 51 per cent stake.
Once confined to secret chambers, hackers now operate even at the behest of nations - all with the stealth shown by the Greeks to destroy Troy with the Trojan horse.
Firstsource was perhaps the first BPO that set shop in the US city of Buffalo in 2004 with 287 employees.
In this emerging trend, doctors are joining hands with venture capitalists, drug firms and medical equipment vendors to set up advanced medical care facilities at low costs.
This metro line would be a 33.65-km rail link between Bangalore City Centre and Bangalore International Airport.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances